ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology, Inc.(OTCBB: ACTC): On June 21, 2007, the U.S. Senate Appropriations Committee voted overwhelmingly in favor of a $152 billion Labor-HHS-Education appropriations bill. An amendment to the bill would expand federal funding for embryonic stem cell research by changing a critical date relating to the eligibility of stem cell lines. The amendment would fundamentally change current federal embryonic stem cell policy by permitting federally-funded research on stem cell lines that were derived before June 15 of this year, as opposed to the current marker of August 9, 2001. The committee noted that this moving of the date forward by almost six years will advance progress toward treatments and cures by significantly expanding the number of stem cell lines eligible for federally funded research.
